Skip to main content

Advertisement

Table 2 HRQOL of different patient groups and discriminative validity of the EQ-5D-5L

From: Quality of life profile and psychometric properties of the EQ-5D-5L in HIV/AIDS patients

  N % EQ-5D Index VAS
Mean    p-value Mean    p-value
All patients 1016 100.0 0.65 0.63 0.67   70.34 69.17 71.51  
HIV Stages
- Asymptomatic 126 12.4 0.73 0.69 0.77 <0.01 76.67 74.14 79.20 <0.01
- Symptomatic 508 50.0 0.65 0.63 0.67   70.72 69.15 72.29  
- AIDS 382 37.6 0.62 0.59 0.66   67.79 65.66 69.91  
CD4
<=200 249 31.1 0.58 0.54 0.61 <0.01 64.47 61.80 67.14 <0.01
200<cd4<=350 249 31.1 0.66 0.62 0.69   71.62 69.43 73.81  
350<cd4<=500 194 24.2 0.73 0.70 0.75   75.57 73.48 77.65  
>500 109 13.6 0.69 0.65 0.74   76.22 73.20 79.24  
Duration of ART
Not yet 114 11.2 0.64 0.59 0.69 <0.01 68.15 64.50 71.80 <0.01
<=1 yr 196 19.3 0.58 0.54 0.62   65.53 62.57 68.50  
1; <=2 144 14.2 0.65 0.61 0.69   71.54 68.58 74.49  
2; <=4 270 26.6 0.68 0.65 0.71   71.76 69.56 73.95  
4; <=7 292 28.7 0.68 0.64 0.71   72.52 70.44 74.60  
IDU
- No 548 53.9 0.66 0.63 0.68 0.48 71.29 69.72 72.85 0.09
- Yes 468 46.1 0.64 0.62 0.67   69.24 67.46 71.01  
AUDIT-positive
- No 710 69.9 0.67 0.65 0.69 <0.01 71.73 70.40 73.07 <0.01
- Yes 306 30.1 0.60 0.57 0.63   67.12 64.78 69.47  
Optimal ART adherence
- No 660 75.3 0.65 0.63 0.67 0.91 71.15 69.69 72.62 0.47
- Yes 217 24.7 0.65 0.62 0.69   70.09 67.73 72.44